Screening and evaluation of potential recipients and donors for living donor uterus transplantation: results from a single-center observational study.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 07 2018
revised: 12 09 2018
accepted: 13 09 2018
entrez: 7 1 2019
pubmed: 7 1 2019
medline: 26 4 2019
Statut: ppublish

Résumé

To report our experience with the screening and selection of potential recipients and living donors of our uterus transplantation (UTx) program. Part of an observational program. University hospital. Patients with absolute uterine factor infertility (AUFI). Screening by e-mail and telephone, selection during surgical consultation, and preoperative investigations according to a multistep procedure for living donation. Age, cause of AUFI, exclusion reasons, and preoperative workup. A total of 212 potential recipients expressed interest in participation. Among the 46 potential recipients and 49 directed donors were 4 potential recipients, each with 2 directed donors. Mean (range) age of potential recipients was 29.6 (19-41) years. Of the potential recipients, 39 (84.8%) had congenital AUFI and 7 (17.3%) had acquired AUFI. Ultimately, 15 potential recipients with 16 directed donors were selected for participation, with 1 potential recipient having 2 directed donors. Mean age of included potential recipients was 28.9 (22-35) years, and mean donor age was 51.3 (37-62) years. Fourteen potential recipients (93.3%) had congenital AUFI, and one potential recipient (6.7%) had undergone hysterectomy for obstetric complications. The number of potential candidates for UTx is not inconsiderable, with congenital AUFI being the leading cause of AUFI in our cohort. However, our findings highlight that large numbers of AUFI patients need to be screened, considering our exclusion rates were >50%, owing to ABO incompatibility, unavailability of a directed donor, and self-withdrawal. Moreover, meticulous preoperative screening, including in-depth psychological assessment, is mandatory to maximize living donor safety and UTx success.

Identifiants

pubmed: 30611405
pii: S0015-0282(18)32039-9
doi: 10.1016/j.fertnstert.2018.09.010
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-193

Informations de copyright

Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Florin-Andrei Taran (FA)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany. Electronic address: florin-andrei.taran@med.uni-tuebingen.de.

Dorit Schöller (D)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Katharina Rall (K)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Silvio Nadalin (S)

Department of General, Visceral, and Transplant Surgery, University of Tübingen, Tübingen, Germany.

Alfred Königsrainer (A)

Department of General, Visceral, and Transplant Surgery, University of Tübingen, Tübingen, Germany.

Melanie Henes (M)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Hans Bösmüller (H)

Department of Pathology, University of Tübingen, Tübingen, Germany.

Falko Fend (F)

Department of Pathology, University of Tübingen, Tübingen, Germany.

Konstantin Nikolaou (K)

Department of Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Germany.

Mike Notohamiprodjo (M)

Department of Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Germany.

Christian Grasshoff (C)

Department of Anesthesiology and Intensive Care Medicine, University of Tübingen, Tübingen, Germany.

Eckhard Heim (E)

Department of Anesthesiology and Intensive Care Medicine, University of Tübingen, Tübingen, Germany.

Stephan Zipfel (S)

Department of Psychosomatic Medicine, University of Tübingen, Tübingen, Germany.

Norbert Schäffeler (N)

Department of Psychosomatic Medicine, University of Tübingen, Tübingen, Germany.

Tamam Bakchoul (T)

Center for Transfusion Medicine, University of Tübingen, Tübingen, Germany.

Nils Heyne (N)

Department of Endocrinology and Diabetology, Angiology, Nephrology, and Clinical Chemistry, University of Tübingen, Tübingen, Germany.

Martina Guthoff (M)

Department of Endocrinology and Diabetology, Angiology, Nephrology, and Clinical Chemistry, University of Tübingen, Tübingen, Germany.

Bernhard Krämer (B)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Christl Reisenauer (C)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Markus Hoopmann (M)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Karl-Oliver Kagan (KO)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Mats Brännström (M)

Department of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden; Stockholm IVF, Stockholm, Sweden.

Diethelm Wallwiener (D)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Sara Y Brucker (SY)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH